Contributing to the FMD Global Strategy Country Survey Preliminary Results Nairobi 26-30 January 2009
1. Objectives of the survey To assess the level of FMD risk management in Africa (for countries non officially free of FMD) To obtain baseline information for regional* and global advocacy the development of the Global FMD Strategy (national and regional* dimensions) To start sensibilizing countries on the Issue Not to rank countries *Already used for Middle-east countries; Planned for Asian countries
2. Questionnaire Q1 Current status(with regard to progressive control stages 0 5) Q2 Actions neededto move to the next 1 and 2 stages, and difficulties to solve Q3 Time neededto move to the next 1 and 2 stages Q4 Kind of international assistance needed
3. Process Use of the tooldeveloped by FAO (part of the progressive FMD risk reduction approach; see previous presentation) level 0 to 5 Questionnaire (4 questions) Launched on January 7; reply deadline on January 19 Survey via the CVOs Legend used: Level 0 Level 1 National Zone Level 2 Level 3 Level 4 Level 5 Other No response
4. Response rate 56 survey forms sent (all African countries including Mayotte and La Réunion; 2 countries non OIE member = Liberia and Seychelles) 29 responses 2 countries (who had not responded) with OIE official status (Mauritius; South Africa) Response rate = 55% Questionnaires retournés vierge (1), incomplets (5)
5. Results Q1 Current status
5. Results Q1 Current status Level 0 Level 1 Level 2 Level 3 Level 4 Level 5 N Z Other No response
5. Results Q1 Current status Insufficient data (in particular for central and eastern Africa) Sub-regional level (North Africa = 3; West Africa = 0; South Africa = >2) Wide range of responses, including zoned countries Countries difficult to range: Lesotho, Rwanda: no occurrence since many years (while no circulation study or surveillance) Seychelles: level 5 (but not an OIE member country)
6. Results Q2 Actions needed / difficulties for the next steps Countries at level 0 Required activities Actions needed Passage to Level 1 1. Level of virus circulation studied 2. Critical risk points identified 3. Strategy under development Diagnostic kits / reagents available Lab staff trained Seroprevalence / virus identification studies conducted Risk analysis conducted Strategic vaccination studied Breeders sensibilized Passage to Level 2 4. Level of virus circulation studied repeatedly 5. Outbreaks investigation, sources identified 6. Risk identified for each chain, adapted strategies implemented 7. Impact of control measures assessed FMD surveillance (passive and active) in place (stakeholders trained; functional nat. epid. network) Contingency plans existing and implemented Cross border collaboration; movement control Quality vaccines available / affordable (Mass - strategic) vaccination implemented Vaccines R&D in place Outbreaks declared to OIE Difficulties Lack of resources: financial, HR, logistical (facilities) Lack of knowledge, information, awareness Legislation inadequate Lack of cross-border, sub-regional, regional coordination (notably for transhumant countries)
6. Results Q2 Actions needed / difficulties for the next steps Countries at level 3 Required activities Actions needed Difficulties Passage to Level 4 1. No outbreakof FMD for the past 2years and no evidence of FMDV circulation for the past 12 months, 2. Surveillancefor FMD and FMDV circulation in accordance with the OIE Code is in operation; regulatory measures for the prevention and control of FMD have been implemented (documented evidence) 3. Routine vaccination is carried out for the purpose of the prevention of FMD (documented evidence) 4. Vaccine used complies with the standards described in the Terrestrial Manual(documented evidence) Surveillance program maintained, reinforced Dossier OIE (free withvaccination status) prepared and submitted to OIE -Resources (HR, material, logistic) to carry out proper surveillance - Expertise and funds for the Dossier OIE Passage to Level 5 5. No outbreakof FMD for the past 2years and no evidence of FMDV circulation for the past 12 months, 6. Surveillancefor FMD and FMDV circulation in accordance with the OIE Code is in operation; regulatory measures for the prevention and control of FMD have been implemented (documented evidence) 7. Vaccination is not carried out Surveillance program maintained, reinforced Dossier OIE (free withoutvaccination status) prepared and submitted to OIE -Identification / traceability of all sensible species - Control of animal movement - Respect of biosecurity measures -FMD status in the sub-region - Availability of Funds - Expertise and funds for the Dossier OIE
6. Results Q2 Actions needed / difficulties for the next steps Specific issues for zoned countries Actions needed Difficulties Surveillance improve, notably in wildlife Livestock movements controlled Livestock identified Country subdivided into smaller zones - Links with wildlife authorities, and surveillance strengthening in parks - Establishment of check points; additional mobile patrols -Extensive / communal grazing systems, with infrastructures like watering points, dip tanks, improved pasture and marketing - Fences, demarcation issues Passage to the next Level - Overall: funding issues
7. Results Q3 Next 2 levels chronogram
7. Results Q3 Next 2 levels chronogram 2009 2010 2011 2012 2013-2014
7. Results Q3 Next 2 levels chronogram Not all the countries have provided chronogram (Togo; Ivory Coast; Burundi...) Result show that next level is reachable: For countries at level 0 in 1 year for 36% in 1 to 2 year for 7% in 2 years for 42% in 3 and more years for 14% For countries at level 2 In 1 year for 100% For countries at level 3 (N or Z) In 1 year for 66% In 3 to 4 years for 33%
8. Results Q4 International assistance Specific support Epidemiology ++ Preparedness + + Labs capacities + + + Surveillance capacities + + + Control capacities + + Vaccines + + Socio-economic studies + + OIE dossier + + Regional approach / program + + Accompanying measures VS strengthening (OIE PVS) + Public awareness + Livestock chains structuration / organization + Identification / traceability animals + Funding + + + mentioned [1 time]; + + mentioned [2; 5 times]; + + + mentioned [6; 10 times]
8. Results Q4 International assistance Specific support requested (1/2) Epidemiology Epidemiological national surveys / serotype identification + + Epidemiology training + Preparedness Emergency preparedness + Contingency plan + Legislation actualization and harmonization: + Experts advices: + Surveillance capacities Surveillance CB: +++(including stakeholders disease reporting ++) Labs capacities Provision of material: reagent ++; testing kits ++; sampling material + Diagnostic CB: +++ Overall lab CB: ++
8. Results Q4 International assistance Specific support requested (2/2) Control capacities Emergency support (in case of outbreaks): ++ Vaccines Vaccines provision ++ Vaccination program ++ Vaccines development and production: + Socio-economic studies Global +, regional + and national ++ impact of the disease Import risk analysis + Risk analysis for each livestock chain+ OIE dossier dossier information + ; Dossier preparation + ; Dossier funding + Zoning creating free zones + Regional approach / program + + (notably Sahelian countries)
9. Conclusions Limits of the questionnaire (to be refined) Preliminary results (to be continued) Sub-regional / regional approach strongly emphasized So far, 3 different levels (North = 3, West = 0, South= >2) 3 roadmaps? 3 strategies? 3 levels of assistance from the international community?